과제정보
I thank Dr. Sunjoo Jeong both for the excellent work she did in my lab as a graduate student years ago and for the invitation to write this review. I am grateful to people who contributed to genome editing research in my lab over many years, to colleagues with whom I have had fruitful discussion about CRISPR technology-its uses and misuses-and to the many people who have advanced the field of genome editing in marvelous and sometimes surprising ways.
참고문헌
- Amoasii, L., Hildyard, J.C.W., Li, H., Sanchez-Ortiz, E., Mireault, A., Caballero, D., Harron, R., Stathopoulou, T.R., Massey, C., Shelton, J.M., et al. (2018). Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Science 362, 86-91. https://doi.org/10.1126/science.aau1549
- Anzalone, A.V., Koblan, L.W., and Liu, D.R. (2020). Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824-844. https://doi.org/10.1038/s41587-020-0561-9
- Anzalone, A.V., Randolph, P.B., Davis, J.R., Sousa, A.A., Koblan, L.W., Levy, J.M., Chen, P.J., Wilson, C., Newby, G.A., Raguram, A., et al. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149-157. https://doi.org/10.1038/s41586-019-1711-4
- Carroll, D. (2014). Genome engineering with targetable nucleases. Annu. Rev. Biochem. 83, 409-439. https://doi.org/10.1146/annurev-biochem-060713-035418
- Carroll, D. (2019). Collateral damage: benchmarking off-target effects in genome editing. Genome Biol. 20, 114.
- Carroll, D. and Charo, R.A. (2015). The societal opportunities and challenges of genome editing. Genome Biol. 16, 242.
- Dabbous, O., Maru, B., Jansen, J.P., Lorenzi, M., Cloutier, M., Guerin, A., Pivneva, I., Wu, E.Q., Arjunji, R., Feltner, D., et al. (2019). Survival, motor function, and motor milestones: comparison of AVXS-101 relative to nusinersen for the treatment of infants with spinal muscular atrophy type 1. Adv. Ther. 36, 1164-1176. https://doi.org/10.1007/s12325-019-00923-8
- De Vivo, D.C., Bertini, E., Swoboda, K.J., Hwu, W.L., Crawford, T.O., Finkel, R.S., Kirschner, J., Kuntz, N.L., Parsons, J.A., Ryan, M.M., et al. (2019). Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the Phase 2 NURTURE study. Neuromuscul. Disord. 29, 842-856. https://doi.org/10.1016/j.nmd.2019.09.007
- Frangoul, H., Altshuler, D., Cappellini, M.D., Chen, Y.S., Domm, J., Eustace, B.K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021). CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 384, 252-260. https://doi.org/10.1056/NEJMoa2031054
- Gaudelli, N.M., Komor, A.C., Rees, H.A., Packer, M.S., Badran, A.H., Bryson, D.I., and Liu, D.R. (2017). Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage. Nature 551, 464-471. https://doi.org/10.1038/nature24644
- Gillmore, J.D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M.L., Seitzer, J., O'Connell, D., Walsh, K.R., Wood, K., et al. (2021). CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493-502. https://doi.org/10.1056/NEJMoa2107454
- Herrick, J.B. (1910). Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch. Intern. Med. (Chic.) 6, 517-521. https://doi.org/10.1001/archinte.1910.00050330050003
- Ingram, V.M. (1957). Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180, 326-328. https://doi.org/10.1038/180326a0
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., and Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821. https://doi.org/10.1126/science.1225829
- Kanter, J., Walters, M.C., Krishnamurti, L., Mapara, M.Y., Kwiatkowski, J.L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K.A., Pierciey, F.J., Jr., Bonner, M., et al. (2022). Biologic and clinical efficacy of LentiGlobin for sickle cell disease. N. Engl. J. Med. 386, 617-628. https://doi.org/10.1056/NEJMoa2117175
- Keynes, M. and Cox, T.M. (2008). William Bateson, the rediscoverer of Mendel. J. R. Soc. Med. 101, 104.
- Komor, A.C., Kim, Y.B., Packer, M.S., Zuris, J.A., and Liu, D.R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420-424. https://doi.org/10.1038/nature17946
- Lattanzi, A., Camarena, J., Lahiri, P., Segal, H., Srifa, W., Vakulskas, C.A., Frock, R.L., Kenrick, J., Lee, C., Talbott, N., et al. (2021). Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease. Sci. Transl. Med. 13, eabf2444.
- Lawn, R.M., Fritsch, E.F., Parker, R.C., Blake, G., and Maniatis, T. (1978). The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA. Cell 15, 1157-1174. https://doi.org/10.1016/0092-8674(78)90043-0
- Levy, J.M., Yeh, W.H., Pendse, N., Davis, J.R., Hennessey, E., Butcher, R., Koblan, L.W., Comander, J., Liu, Q., and Liu, D.R. (2020). Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97-110. https://doi.org/10.1038/s41551-019-0501-5
- Li, C. and Samulski, R.J. (2020). Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255-272. https://doi.org/10.1038/s41576-019-0205-4
- Liu, N., Hargreaves, V.V., Zhu, Q., Kurland, J.V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J.M., Kurita, R., et al. (2018). Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch. Cell 173, 430-442.e17. https://doi.org/10.1016/j.cell.2018.03.016
- Maeder, M.L., Stefanidakis, M., Wilson, C.J., Baral, R., Barrera, L.A., Bounoutas, G.S., Bumcrot, D., Chao, H., Ciulla, D.M., DaSilva, J.A., et al. (2019). Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat. Med. 25, 229-233. https://doi.org/10.1038/s41591-018-0327-9
- Magis, W., DeWitt, M.A., Wyman, S.K., Vu, J.T., Heo, S.J., Shao, S.J., Hennig, F., Romero, Z.G., Campo-Fernandez, B., Said, S., et al. (2022). High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation. iScience 25, 104374.
- National Academy of Medicine, National Academy of Sciences, and The Royal Society (2020). Heritable Human Genome Editing (Washington, DC: National Academies Press).
- National Academies of Sciences, Engineering, and Medicine (2017). Human Genome Editing: Science, Ethics, and Governance (Washington, DC: National Academies Press).
- Newby, G.A., Yen, J.S., Woodard, K.J., Mayuranathan, T., Lazzarotto, C.R., Li, Y., Sheppard-Tillman, H., Porter, S.N., Yao, Y., Mayberry, K., et al. (2021). Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature 595, 295-302. https://doi.org/10.1038/s41586-021-03609-w
- Pauling, L., Itano, H.A., Singer, S.J., and Weiss, I.G. (1949). Sickle cell anemia a molecular disease. Science 110, 543-548. https://doi.org/10.1126/science.110.2865.543
- Stadtmauer, E.A., Fraietta, J.A., Davis, M.M., Cohen, A.D., Weber, K.L., Lancaster, E., Mangan, P.A., Kulikovskaya, I., Gupta, M., Chen, F., et al. (2020). CRISPR-engineered T cells in patients with refractory cancer. Science 367, eaba7365.
- Tebas, P., Jadlowsky, J.K., Shaw, P.A., Tian, L., Esparza, E., Brennan, A.L., Kim, S., Naing, S.Y., Richardson, M.W., Vogel, A.N., et al. (2021). CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. J. Clin. Invest. 131, e144486.
- Tebas, P., Stein, D., Tang, W.W., Frank, I., Wang, S.Q., Lee, G., Spratt, S.K., Surosky, R.T., Giedlin, M.A., Nichol, G., et al. (2014). Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N. Engl. J. Med. 370, 901-910. https://doi.org/10.1056/NEJMoa1300662
- Wang, D., Zhang, F., and Gao, G. (2020). CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136-150. https://doi.org/10.1016/j.cell.2020.03.023
- World Health Organization (2021a). Human Genome Editing: Recommendations (Geneva: World Health Orgainzation).
- World Health Organization (2021b). Human Genome Editing: Position Paper (Geneva: World Health Orgainzation).
- Wilson, J.T., Wilson, L.B., deRiel, J.K., Villa-komaroff, L., Efstratiadis, A., Forget, B.G., and Weissman, S.M. (1978). Insertion of synthetic copies of human globin genes into bacterial plasmids. Nucleic Acids Res. 5, 563-581. https://doi.org/10.1093/nar/5.2.563
- Wilson, R.C. and Carroll, D. (2019). The daunting economics of therapeutic genome editing. CRISPR J. 2, 280-284. https://doi.org/10.1089/crispr.2019.0052
- Xue, C. and Greene, E.C. (2021). DNA repair pathway choices in CRISPR-Cas9-mediated genome editing. Trends Genet. 37, 639-656. https://doi.org/10.1016/j.tig.2021.02.008